JP2014139220A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014139220A5 JP2014139220A5 JP2014061763A JP2014061763A JP2014139220A5 JP 2014139220 A5 JP2014139220 A5 JP 2014139220A5 JP 2014061763 A JP2014061763 A JP 2014061763A JP 2014061763 A JP2014061763 A JP 2014061763A JP 2014139220 A5 JP2014139220 A5 JP 2014139220A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- drug
- administered
- parathyroid hormone
- risk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9715198P | 1998-08-19 | 1998-08-19 | |
| US60/097,151 | 1998-08-19 | ||
| US9974698P | 1998-09-10 | 1998-09-10 | |
| US60/099,746 | 1998-09-10 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010244314A Division JP2011021035A (ja) | 1998-08-19 | 2010-10-29 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014204577A Division JP2015028065A (ja) | 1998-08-19 | 2014-10-03 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014139220A JP2014139220A (ja) | 2014-07-31 |
| JP2014139220A5 true JP2014139220A5 (2) | 2014-09-25 |
| JP6177718B2 JP6177718B2 (ja) | 2017-08-09 |
Family
ID=26792729
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000565916A Pending JP2002523375A (ja) | 1998-08-19 | 1999-08-19 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
| JP2010244314A Withdrawn JP2011021035A (ja) | 1998-08-19 | 2010-10-29 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
| JP2014061763A Expired - Lifetime JP6177718B2 (ja) | 1998-08-19 | 2014-03-25 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
| JP2014204577A Withdrawn JP2015028065A (ja) | 1998-08-19 | 2014-10-03 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
| JP2017124301A Withdrawn JP2017190332A (ja) | 1998-08-19 | 2017-06-26 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000565916A Pending JP2002523375A (ja) | 1998-08-19 | 1999-08-19 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
| JP2010244314A Withdrawn JP2011021035A (ja) | 1998-08-19 | 2010-10-29 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014204577A Withdrawn JP2015028065A (ja) | 1998-08-19 | 2014-10-03 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
| JP2017124301A Withdrawn JP2017190332A (ja) | 1998-08-19 | 2017-06-26 | 骨の靭性、及び、剛性を増し、骨折を減少させる方法 |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6977077B1 (2) |
| EP (3) | EP2266598B1 (2) |
| JP (5) | JP2002523375A (2) |
| KR (1) | KR100454207B1 (2) |
| CN (1) | CN1205997C (2) |
| AR (1) | AR033639A1 (2) |
| AT (1) | ATE231000T1 (2) |
| AU (1) | AU746277B2 (2) |
| BR (1) | BR9909445A (2) |
| CA (1) | CA2325371C (2) |
| CO (1) | CO5130020A1 (2) |
| CY (2) | CY1113343T1 (2) |
| CZ (1) | CZ301017B6 (2) |
| DE (2) | DE15152726T1 (2) |
| DK (4) | DK2266598T3 (2) |
| DZ (1) | DZ2873A1 (2) |
| EA (1) | EA003362B1 (2) |
| ES (4) | ES2393200T3 (2) |
| HR (1) | HRP20000755A2 (2) |
| HU (2) | HU1200430D0 (2) |
| ID (1) | ID29039A (2) |
| IL (2) | IL138829A0 (2) |
| MY (1) | MY129227A (2) |
| NO (2) | NO323984B1 (2) |
| NZ (1) | NZ507056A (2) |
| PE (1) | PE20001089A1 (2) |
| PL (1) | PL201688B1 (2) |
| PT (4) | PT1769804E (2) |
| TR (1) | TR200003455T2 (2) |
| TW (1) | TW576747B (2) |
| UA (1) | UA72205C2 (2) |
| WO (1) | WO2000010596A1 (2) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6770623B1 (en) * | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
| US20040033950A1 (en) * | 2000-09-26 | 2004-02-19 | Hock Janet M. | Method of increasing bone toughness and stiffness and reducing fractures |
| DZ2873A1 (fr) | 1998-08-19 | 2003-12-15 | Lilly Co Eli | Procédé pour augmenter la dureté et la rigidité osseuse. |
| CA2387693A1 (en) * | 1999-09-20 | 2001-03-29 | Eli Lilly And Company | Method for monitoring treatment with a parathyroid hormone |
| US7247609B2 (en) | 2001-12-18 | 2007-07-24 | Universitat Zurich | Growth factor modified protein matrices for tissue engineering |
| AU2003207512B2 (en) | 2002-01-10 | 2008-06-12 | Osteotrophin Llc | Treatment of bone disorders with skeletal anabolic drugs |
| US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
| KR20060058133A (ko) * | 2003-09-19 | 2006-05-29 | 화이자 프로덕츠 인코포레이티드 | 2-알킬리덴-19-노르-비타민 ｄ 유도체 및 부갑상선호르몬의 조합을 포함하는 약학 조성물 및 방법 |
| MXPA06012980A (es) * | 2004-05-10 | 2007-06-12 | Nastech Pharm Co | Composiciones y metodos para el suministro mucosal mejorado de la hormona paratiroidea. |
| US20060052305A1 (en) * | 2004-05-10 | 2006-03-09 | Nastech Pharmaceutical Company Inc. | Method of treating osteoporosis using intranasal parathyroid hormone |
| US20060127320A1 (en) * | 2004-05-10 | 2006-06-15 | Nastech Pharmaceutical Company Inc. | Method of delivering parathyroid hormone to a human |
| US20060189533A1 (en) * | 2004-05-10 | 2006-08-24 | Nastech Pharmaceutical Company Inc. | Stable pharmaceutical dosage forms of teriparatide |
| MXPA06013168A (es) | 2004-05-13 | 2007-05-15 | Johnson & Johnson | Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea. |
| US7648965B2 (en) | 2004-05-14 | 2010-01-19 | Unigene Laboratories Inc. | Method for fostering bone formation and preservation |
| US20060069021A1 (en) * | 2004-08-13 | 2006-03-30 | Nastech Pharmaceutical Company Inc. | Compositions and methods for intranasal administration of inactive analogs of PTH or inactivated preparations of PTH or PTH analogs |
| WO2006073711A2 (en) | 2005-01-06 | 2006-07-13 | Kuros Biosurgery Ag | Use of a matrix comprising a contrast agent in soft tissues |
| US8575101B2 (en) | 2005-01-06 | 2013-11-05 | Kuros Biosurgery Ag | Supplemented matrices for the repair of bone fractures |
| JP2008540522A (ja) * | 2005-05-11 | 2008-11-20 | ユニジーン・ラボラトリーズ・インコーポレーテッド | 骨の形成および保存を促進するための方法 |
| US20070173447A1 (en) * | 2005-10-25 | 2007-07-26 | Nastech Pharmaceutical Company Inc. | Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent |
| CN101355959B (zh) * | 2005-11-10 | 2013-02-27 | 密歇根理工大学管理委员会 | 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法 |
| US20080051332A1 (en) * | 2005-11-18 | 2008-02-28 | Nastech Pharmaceutical Company Inc. | Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone |
| US20080119408A1 (en) * | 2006-07-07 | 2008-05-22 | Nastech Pharmaceutical Company Inc. | Pth formulations for intranasal delivery |
| EP1961765A1 (en) * | 2006-12-08 | 2008-08-27 | Zealand Pharma A/S | Truncated PTH peptides with a cyclic conformation |
| PL2136850T3 (pl) | 2007-04-13 | 2012-07-31 | Kuros Biosurgery Ag | Polimeryczny uszczelniacz tkankowy |
| US20110137243A1 (en) * | 2007-09-06 | 2011-06-09 | Abbott Cardiovascular Systems Inc. | Coating On A Balloon Device |
| US9457056B2 (en) * | 2007-12-04 | 2016-10-04 | Ben-Gurion University Of The Negev Research And Development Authority | Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis |
| CA2710798A1 (en) | 2007-12-28 | 2009-07-09 | Kuros Biosurgery Ag | Pdgf fusion proteins incorporated into fibrin foams |
| ES2662018T3 (es) * | 2009-09-09 | 2018-04-05 | Asahi Kasei Pharma Corporation | Agente terapéutico/profiláctico que contiene PTH para la osteoporosis, caracterizado porque la PTH se administra una vez por semana en una dosis unitaria de 200 unidades |
| EP2509996A1 (en) | 2009-12-07 | 2012-10-17 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| US9295663B2 (en) | 2010-07-14 | 2016-03-29 | Abbott Cardiovascular Systems Inc. | Drug coated balloon with in-situ formed drug containing microspheres |
| WO2012111852A1 (ja) * | 2011-02-17 | 2012-08-23 | 帝人ファーマ株式会社 | 椎体骨折治療剤及びその評価方法 |
| EP2686027B1 (en) | 2011-03-16 | 2021-05-05 | Kuros Biosurgery AG | Pharmaceutical formulation for use in spinal fusion |
| WO2012169435A1 (ja) | 2011-06-07 | 2012-12-13 | 旭化成ファーマ株式会社 | 高純度ｐｔｈ含有凍結乾燥製剤およびその製造方法 |
| US9700485B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| CA3013443C (en) | 2016-02-01 | 2021-06-15 | Eli Lilly And Company | Parathyroid hormone - anti-rankl antibody fusion compounds |
| US20190381341A1 (en) * | 2017-02-01 | 2019-12-19 | The Johns Hopkins University | Parathyroid hormone and regeneration of degenerative discs disease |
| JP6577683B2 (ja) * | 2017-09-22 | 2019-09-18 | 旭化成ファーマ株式会社 | 安定性に優れるテリパラチド含有液状医薬組成物 |
| JP6618139B1 (ja) | 2018-10-29 | 2019-12-11 | 旭化成ファーマ株式会社 | 週２回の頻度でテリパラチド又はその塩を投与することを特徴とする、骨粗鬆症の予防又は治療方法 |
| US12344649B2 (en) | 2019-08-09 | 2025-07-01 | Flagship Pioneering Innovations Vi, Llc | Modulators of parathyroid hormone receptor (PTHR1) |
| GB2590692A (en) * | 2019-12-24 | 2021-07-07 | Corthotec Ltd | Composition for improved bone fracture healing |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4086196A (en) | 1975-03-28 | 1978-04-25 | Armour Pharmaceutical Company | Parathyroid hormone |
| IL78342A (en) | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
| DE3935738A1 (de) | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff |
| US5208041A (en) | 1991-05-23 | 1993-05-04 | Allelix Biopharmaceuticals Inc. | Essentially pure human parathyroid hormone |
| CA2126299C (en) | 1994-06-20 | 2000-12-12 | Gordon E. Willick | Parathyroid hormone analogues for the treatment of osteoporosis |
| JPH0873376A (ja) | 1994-09-07 | 1996-03-19 | Asahi Chem Ind Co Ltd | 骨粗鬆症治療薬 |
| US5747456A (en) * | 1994-12-19 | 1998-05-05 | Beth Israel Deaconess Medical Center | Continuous low-dose administration of parathyroid hormone or its agonist |
| WO1996019246A1 (en) * | 1994-12-19 | 1996-06-27 | Beth Israel Hospital Association | Continuous low-dose administration of parathyroid hormone or its agonist |
| CA2206657C (en) * | 1994-12-22 | 2009-05-19 | Astra Aktiebolag | Therapeutic preparation for inhalation containing parathyroid hormone, pth |
| JPH08310965A (ja) | 1995-05-16 | 1996-11-26 | Chugai Pharmaceut Co Ltd | 骨癒合促進剤 |
| RS49707B (sr) * | 1997-09-09 | 2007-12-31 | F.Hoffmann-La Roche Ag., | Primena polipeptidnog analoga peptida srodnog paratireoidnom hormonu i njegovih soli za proizvodnju medikamenata za lečenje preloma kostiju |
| ZA9811127B (en) | 1997-12-09 | 2000-07-11 | Lilly Co Eli | Stabilized teriparatide solutions. |
| DZ2873A1 (fr) * | 1998-08-19 | 2003-12-15 | Lilly Co Eli | Procédé pour augmenter la dureté et la rigidité osseuse. |
| US20040033950A1 (en) | 2000-09-26 | 2004-02-19 | Hock Janet M. | Method of increasing bone toughness and stiffness and reducing fractures |
| US6907597B1 (en) | 2000-10-13 | 2005-06-14 | Ati International Srl | Method and apparatus for constructing an executable program in memory |
| US6967759B2 (en) | 2001-12-31 | 2005-11-22 | Texas Instruments Incorporated | Pulse width modulation sequence generation |
| JP5796714B2 (ja) | 2012-01-13 | 2015-10-21 | 株式会社リコー | 定着装置及び画像形成装置 |
| EP2949301B1 (en) | 2014-05-27 | 2018-04-18 | The Procter and Gamble Company | Absorbent core with curved and straight absorbent material areas |
-
1999
- 1999-08-18 DZ DZ990173A patent/DZ2873A1/xx active
- 1999-08-18 AR ARP990104133A patent/AR033639A1/es unknown
- 1999-08-19 AT AT99942350T patent/ATE231000T1/de not_active IP Right Cessation
- 1999-08-19 DE DE15152726.4T patent/DE15152726T1/de active Pending
- 1999-08-19 DK DK10180447.4T patent/DK2266598T3/en active
- 1999-08-19 EP EP10180447.4A patent/EP2266598B1/en not_active Expired - Lifetime
- 1999-08-19 PE PE1999000839A patent/PE20001089A1/es not_active Application Discontinuation
- 1999-08-19 KR KR10-2001-7002092A patent/KR100454207B1/ko not_active Expired - Lifetime
- 1999-08-19 BR BR9909445-2A patent/BR9909445A/pt not_active Application Discontinuation
- 1999-08-19 ES ES06027055T patent/ES2393200T3/es not_active Expired - Lifetime
- 1999-08-19 CO CO99052525A patent/CO5130020A1/es unknown
- 1999-08-19 US US09/647,278 patent/US6977077B1/en not_active Expired - Lifetime
- 1999-08-19 EP EP15152726.4A patent/EP2907522B1/en not_active Revoked
- 1999-08-19 CZ CZ20004134A patent/CZ301017B6/cs not_active IP Right Cessation
- 1999-08-19 ES ES10180447.4T patent/ES2621653T3/es not_active Expired - Lifetime
- 1999-08-19 UA UA2000095457A patent/UA72205C2/uk unknown
- 1999-08-19 AU AU55750/99A patent/AU746277B2/en not_active Expired
- 1999-08-19 HR HR20000755A patent/HRP20000755A2/hr not_active Application Discontinuation
- 1999-08-19 JP JP2000565916A patent/JP2002523375A/ja active Pending
- 1999-08-19 NZ NZ507056A patent/NZ507056A/en not_active IP Right Cessation
- 1999-08-19 DK DK99942350T patent/DK1059933T3/da active
- 1999-08-19 PT PT06027055T patent/PT1769804E/pt unknown
- 1999-08-19 CN CNB998083534A patent/CN1205997C/zh not_active Expired - Lifetime
- 1999-08-19 TR TR2000/03455T patent/TR200003455T2/xx unknown
- 1999-08-19 IL IL13882999A patent/IL138829A0/xx unknown
- 1999-08-19 ES ES15152726.4T patent/ES2549551T3/es not_active Expired - Lifetime
- 1999-08-19 EP EP99942350A patent/EP1059933B1/en not_active Revoked
- 1999-08-19 DE DE69904918T patent/DE69904918T2/de not_active Expired - Lifetime
- 1999-08-19 PT PT101804474T patent/PT2266598T/pt unknown
- 1999-08-19 ID IDW20010612A patent/ID29039A/id unknown
- 1999-08-19 CA CA002325371A patent/CA2325371C/en not_active Expired - Lifetime
- 1999-08-19 PT PT15152726T patent/PT2907522T/pt unknown
- 1999-08-19 WO PCT/US1999/018961 patent/WO2000010596A1/en not_active Ceased
- 1999-08-19 HU HUP1200430 patent/HU1200430D0/hu not_active Application Discontinuation
- 1999-08-19 MY MYPI99003553A patent/MY129227A/en unknown
- 1999-08-19 PT PT99942350T patent/PT1059933E/pt unknown
- 1999-08-19 EA EA200001015A patent/EA003362B1/ru not_active IP Right Cessation
- 1999-08-19 HU HU0101594A patent/HU230697B1/hu unknown
- 1999-08-19 PL PL343595A patent/PL201688B1/pl not_active IP Right Cessation
- 1999-08-19 DK DK15152726.4T patent/DK2907522T3/en active
- 1999-08-19 ES ES99942350T patent/ES2190244T3/es not_active Expired - Lifetime
- 1999-08-19 DK DK06027055.0T patent/DK1769804T3/da active
- 1999-10-26 TW TW088114185A patent/TW576747B/zh not_active IP Right Cessation
-
2000
- 2000-10-03 IL IL138829A patent/IL138829A/en unknown
- 2000-11-24 NO NO20005947A patent/NO323984B1/no not_active IP Right Cessation
-
2005
- 2005-04-05 US US11/098,894 patent/US7163684B2/en not_active Expired - Lifetime
-
2007
- 2007-06-11 NO NO20072983A patent/NO20072983L/no not_active Application Discontinuation
-
2010
- 2010-10-29 JP JP2010244314A patent/JP2011021035A/ja not_active Withdrawn
-
2012
- 2012-11-14 CY CY20121101096T patent/CY1113343T1/el unknown
-
2014
- 2014-03-25 JP JP2014061763A patent/JP6177718B2/ja not_active Expired - Lifetime
- 2014-10-03 JP JP2014204577A patent/JP2015028065A/ja not_active Withdrawn
-
2017
- 2017-06-26 JP JP2017124301A patent/JP2017190332A/ja not_active Withdrawn
- 2017-10-13 CY CY20171101077T patent/CY1119552T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014139220A5 (2) | ||
| WO2014205229A8 (en) | Use of high dose pridopidine for treating huntington's disease | |
| JP2017533972A5 (2) | ||
| NI201100147A (es) | Métodos para tratar infartos agudos de miocardio y trastornos relacionados. | |
| WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
| MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
| NZ617397A (en) | Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units | |
| MY178445A (en) | Novel antibody binding to tfpi and composition comprising the same | |
| CA2986891C (en) | Compositions for use in treating parkinson's disease and related disorders | |
| EP4578461A3 (en) | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa | |
| EP4700016A3 (en) | Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof | |
| JP2016509050A5 (2) | ||
| NZ754328A (en) | Marker for acid sphingomyelinase disorders and uses thereof | |
| HK1255584A1 (zh) | 使用阿坎酸及d-环丝胺酸的联合疗法 | |
| WO2019010301A8 (en) | Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap) | |
| MX2020000164A (es) | Formulaciones de isotretinoína para la mucosa oral y métodos para usar las mismas. | |
| WO2012042197A3 (en) | Low dose pharmaceutical composition comprising zanamivir | |
| RU2020120156A (ru) | Лечение приливов и потери костной ткани, вызванных андрогенной депривационной терапией с применением цис-кломифена | |
| JP2019529569A5 (2) | ||
| EP4389218A3 (en) | Composition for treating joint disease and kit containing same | |
| PH12019502510A1 (en) | Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof | |
| MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. | |
| IN2014DN09240A (2) | ||
| JOP20170044B1 (ar) | تركيبة صيدلانية تشتمل على hgh ناتج عن عودة الارتباط الجيني لعلاج نقص هرمون النمو | |
| MX2018013474A (es) | Acidos carboxilicos para aplicacion en la primera infancia. |